Literature DB >> 8662173

The heparin-induced thrombocytopenia and thrombosis syndrome: treatment with intraarterial urokinase and systemic platelet aggregation inhibitors.

K D Murphy1, G McCrohan, D A DeMarta, N B Shirodkar, O J Kwon, P S Chopra.   

Abstract

We report a case of the heparin-induced thrombocytopenia and thrombosis syndrome presenting with acute ischemia of a lower limb. The patient was successfully treated by withdrawal of heparin products, intraarterial urokinase, and platelet anti-aggregation therapy consisting of Dextran and aspirin.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8662173     DOI： 10.1007/bf02563908

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN： 0174-1551            Impact factor:   2.740


  16 in total

1.  The effect of commercial heparin on the platelet count.

Authors:  E FIDLAR; L B JAQUES
Journal:  J Lab Clin Med       Date:  1948-11

2.  Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients.

Authors:  W R Bell; P A Tomasulo; B M Alving; T P Duffy
Journal:  Ann Intern Med       Date:  1976-08       Impact factor: 25.391

Review 3.  Heparin-induced thrombocytopenia and arterial thrombosis: alternative therapies.

Authors:  C Cola; J Ansell
Journal:  Am Heart J       Date:  1990-02       Impact factor: 4.749

Review 4.  Heparin-induced thrombocytopenia and thrombosis: reversal with streptokinase. A case report and review of literature.

Authors:  D P Mehta; E L Yoder; J Appel; K L Bergsman
Journal:  Am J Hematol       Date:  1991-04       Impact factor: 10.047

5.  Diagnostic and therapeutic strategies of white clot syndrome.

Authors:  A F AbuRahma; J P Boland; T Witsberger
Journal:  Am J Surg       Date:  1991-08       Impact factor: 2.565

6.  Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216).

Authors:  J Leroy; M H Leclerc; B Delahousse; C Guérois; P Foloppe; Y Gruel; F Toulemonde
Journal:  Semin Thromb Hemost       Date:  1985-07       Impact factor: 4.180

7.  Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia.

Authors:  C Demers; J S Ginsberg; P Brill-Edwards; A Panju; T E Warkentin; D R Anderson; C Turner; J G Kelton
Journal:  Blood       Date:  1991-11-01       Impact factor: 22.113

Review 8.  Heparin-induced thrombocytopenia.

Authors:  B H Chong
Journal:  Aust N Z J Med       Date:  1992-04

9.  Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.

Authors:  G P Visentin; S E Ford; J P Scott; R H Aster
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

10.  Heparin-induced platelet activation in sixteen surgical patients: diagnosis and management.

Authors:  J R Kappa; C A Fisher; H D Berkowitz; E D Cottrell; V P Addonizio
Journal:  J Vasc Surg       Date:  1987-01       Impact factor: 4.268
View more
  1 in total

1.  Catastrophic heparin-induced thrombocytopenia/thrombosis syndrome related to the use of a Port-A-Cath in a breast cancer patient receiving chemotherapy.

Authors:  Ming-Shen Dai; An-Tie Hsieh; Tsu-Yi Chao
Journal:  Support Care Cancer       Date:  2004-04-28       Impact factor: 3.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.